SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-003218
Filing Date
2020-01-13
Accepted
2020-01-13 18:47:36
Documents
1
Period of Report
2020-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2358
  Complete submission text file 0001209191-20-003218.txt   4162
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9B RUSSELL STREET CAMBRIDGE MA 01240
Business Address 9B RUSSELL STREET CAMBRIDGE MA 01240 617-229-5085
Opaleye, L.P. (Reporting) CIK: 0001391634 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36694 | Film No.: 20524672